SCHEMBL7222964

SCHEMBL7222964

O=C(O)C=Cc1ccc(-c2nc3c([nH]2)c(=O)n(Cc2ccccc2)c(=O)n3Cc2ccccc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 19/20 1.00
▸ ADORA2A P29274 12/20 0.71
▸ ADORA3 P0DMS8 9/20 0.71
▸ ADORA1 P30542 9/20 0.71
▸ KDM4E B2RXH2 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ CYP1A2 P05177 2/20 0.52
▸ CYP3A4 P08684 2/20 0.52
▸ HSD17B10 Q99714 2/20 0.52
▸ HPGD P15428 1/20 0.52
▸ TSHR P16473 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ THPO P40225 1/20 0.52
▸ PMP22 Q01453 1/20 0.52
▸ MEN1 O00255 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7222961 1.00 ADORA2B (1.00) ADORA2BADORA2AADORA3ADORA1KDM4E
SCHEMBL7228404 0.84 ADORA2B (0.79) ADORA2BADORA2AADORA3ADORA1KDM4E
SCHEMBL7228400 0.84 ADORA2B (0.79) ADORA2BADORA2AADORA3ADORA1KDM4E
SCHEMBL6554077 0.84 ADORA2B (0.72) ADORA2BADORA2AADORA3ADORA1KDM4E
SCHEMBL6554070 0.84 ADORA2B (0.72) ADORA2BADORA2AADORA3ADORA1KDM4E
SCHEMBL7738379 0.83 ADORA2B (1.00) ADORA2BADORA2AADORA3ADORA1KDM4E
SCHEMBL30741228 0.83 ADORA2B (1.00) ADORA2BADORA2AADORA3ADORA1KDM4E
SCHEMBL28795849 0.82 ADORA2B (0.69) ADORA2BADORA2AADORA3ADORA1
SCHEMBL27841466 0.82 ADORA2B (0.88) ADORA2BADORA2AADORA3ADORA1KDM4E
SCHEMBL27859100 0.82 ADORA2B (0.74) ADORA2BADORA2AADORA3ADORA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545002-B1 Treating asthma, diarrhea, insulin resistance, diabetes, ischemia/reprefusion injuries, diabetic retinopathy or hyperbaric oxygen-induced retinopathy UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2003-04-08 — — US disclosed
Send feedback